← Eichor
Condition: Usher Syndromes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Usher Syndromes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843
Natural History Study of Usher Syndrome ( Light4Deaf )
Phase N/A · 4 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT04665726
Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Phase 1/Phase 2 · 3 location(s) · AAVantgarde Bio Srl · NCT06591793
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Phase 1/Phase 2 · 5 location(s) · BlueRock Therapeutics · NCT06789445
Adaptive Optics Imaging of Outer Retinal Diseases
Phase N/A · 2 location(s) · Food and Drug Administration (FDA) · NCT05355415
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Phase N/A · 1 location(s) · Okuvision GmbH · NCT07548944
Inherited Retinal Degenerative Disease Registry
Phase N/A · 1 location(s) · Foundation Fighting Blindness · NCT02435940
Stem Cell Ophthalmology Treatment Study II
NA · 4 location(s) · MD Stem Cells · NCT03011541
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.